Send to

Choose Destination
Vet Clin North Am Equine Pract. 2011 Aug;27(2):275-98. doi: 10.1016/j.cveq.2011.05.001.

Autologous biologic treatment for equine musculoskeletal injuries: platelet-rich plasma and IL-1 receptor antagonist protein.

Author information

Tablin Laboratory, Department of Pathology, Microbiology and Immunology, College of Veterinary Medicine, University of California Davis, VM3A 4318, 1 Shields Avenue, Davis, CA 95616, USA.


Autologous biologic therapies such as platelet-rich plasma and autologous conditioned serum are in widespread clinical use to treat musculoskeletal pathology in horses. These substances exert a therapeutic effect through the provision of either anabolic or anti-catabolic factors, or a combination of both. This article discusses the history, experimental and clinical literature, and currently accepted preparation and usage strategies for both platelet-rich plasma and autologous conditioned serum.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center